Skip to content

The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology

The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05543811
Acronym
Spread Bogatyr
Enrollment
140
Registered
2022-09-16
Start date
2022-09-15
Completion date
2023-02-28
Last updated
2023-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Change, Concentration Ability Impaired, Emotional Regulation, Memory; Disturbance, Mild

Brief summary

This is a single-centre, single-blind, two-arms, controlled study to assess the efficacy and safety of food for special dietary use enriched with 5-hydroxytryptophan, L-theanine and Gamma-aminobutyric acid in generally healthy subjects with no cognitive disturbances

Interventions

DIETARY_SUPPLEMENTFood for special dietary use

Food for special dietary use (spread) with modified ingredients' content will be included to the diet of 70 patients without significant organic pathology for 14 days receiving standard diet, modified by the inclusion of two portions of the spread, 20 grams each for breakfast and dinner

Sponsors

Group of companies EFKO
CollaboratorUNKNOWN
Russian Science Foundation
CollaboratorOTHER
Federal State Budgetary Scientific Institution Federal Research Centre of Nutrition, Biotechnology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* willingness to participate; * age of 18-50 years

Exclusion criteria

* pregnancy or breastfeeding; * significant somatic or psychological disorders

Design outcomes

Primary

MeasureTime frameDescription
change in cognitive functiontwo weekschange in score by Lurie test
change in cognitive function2two weekschange in Kraepelin&Schulte test score
change in functional statustwo weekschange in functional status test score
change in anxiety and depressiontwo weekschange in Beck depression inventory score

Secondary

MeasureTime frameDescription
change in food's taste monotonytwo weekschange in food's taste monotony

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026